학술논문

AUGMENT: RELAPSED/REFRACTORY INDOLENT NHL PATIENTS WERE MORE SENSITIVE TO NEXT TREATMENT FOLLOWING LENALIDOMIDE/RITUXIMAB (R2) THAN RITUXIMAB/PLACEBO.
Document Type
Article
Source
Hematological Oncology; Jun2019 Supplement S2, Vol. 37, p227-229, 3p
Subject
THERAPEUTICS
RITUXIMAB
PLACEBOS
STOCK ownership
Language
ISSN
02780232